Kidney Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Kidney Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 2 (2005), Issue 1 (January)

1. Renal transplantation, immunosuppression and the skin: an update.
   Photodermatol Photoimmunol Photomed, 21(1): 1-8. [Abstract] [Full-text]
2. Disseminated intravascular coagulation (DIC) in a kidney donor associated with transient recipient DIC.
   Am J Transplant, 5(2): 412-4. [Abstract] [Full-text]
3. Association between pulse pressure and cardiovascular disease in renal transplant patients.
   Am J Transplant, 5(2): 394-8. [Abstract] [Full-text]
4. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy.
   Am J Transplant, 5(2): 383-93. [Abstract] [Full-text]
5. Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival.
   Am J Transplant, 5(2): 374-82. [Abstract] [Full-text]
6. BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant.
   Am J Transplant, 5(2): 366-73. [Abstract] [Full-text]
7. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
   Am J Transplant, 5(2): 356-65. [Abstract] [Full-text]
8. Rapid resolution of proteinuria of native kidney origin following live donor renal transplantation.
   Am J Transplant, 5(2): 351-5. [Abstract] [Full-text]
9. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation.
   Am J Transplant, 5(2): 330-40. [Abstract] [Full-text]
10. Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival.
    Am J Transplant, 5(2): 323-9. [Abstract] [Full-text]
11. Repair of damaged organs in vitro.
    Am J Transplant, 5(2): 300-6. [Abstract] [Full-text]
12. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both.
    Am J Transplant, 5(2): 282-91. [Abstract] [Full-text]
13. Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids.
    J Clin Pharmacol, 45(2): 161-7. [Abstract] [Full-text]
14. HBV reactivation after kidney transplantation.
    J Clin Virol, 32(2): 162-5. [Abstract] [Full-text]
15. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Clin Transplant, 19(1): 137-40. [Abstract] [Full-text]
16. Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans' cells in sun exposed and sun protected skin.
    Clin Transplant, 19(1): 115-21. [Abstract] [Full-text]
17. Prevalence, characteristics, and outcome of BK virus nephropathy in Japanese renal transplant patients: analysis in protocol and episode biopsies.
    Clin Transplant, 19(1): 97-101. [Abstract] [Full-text]
18. Living donors' experiences 1 wk after donating a kidney.
    Clin Transplant, 19(1): 90-6. [Abstract] [Full-text]
19. Comparing renal transplant patients' adherence to free cyclosporine and free tacrolimus immunosuppressant therapy.
    Clin Transplant, 19(1): 77-82. [Abstract] [Full-text]
20. Factors modifying stress from adverse effects of immunosuppressive medication in kidney transplant recipients.
    Clin Transplant, 19(1): 70-6. [Abstract] [Full-text]
21. Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies.
    Clin Transplant, 19(1): 61-9. [Abstract] [Full-text]
22. Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease.
    Clin Transplant, 19(1): 56-60. [Abstract] [Full-text]
23. Novel rescue therapy for C4d-positive acute humoral renal allograft rejection.
    Clin Transplant, 19(1): 51-5. [Abstract] [Full-text]
24. A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients.
    Clin Transplant, 19(1): 26-32. [Abstract] [Full-text]
25. The need of mycophenolic acid monitoring in long-term renal transplants.
    Clin Transplant, 19(1): 19-25. [Abstract] [Full-text]
26. Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction.
    Clin Transplant, 19(1): 10-4. [Abstract] [Full-text]
27. EAU guidelines on renal transplantation.
    Eur Urol, 47(2): 156-66. [Abstract] [Full-text]
28. Chronic myeloid leukemia following kidney transplantation.
    Leuk Res, 29(3): 353-5. [Abstract] [Full-text]
29. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Pediatr Transplant, 9(1): 117-21. [Abstract] [Full-text]
30. Improved outcome of pediatric kidney transplantations in the Netherlands -- effect of the introduction of mycophenolate mofetil?
    Pediatr Transplant, 9(1): 104-11. [Abstract] [Full-text]
31. Gastrointestinal leukocytoclastic vasculitis: an adverse effect of sirolimus.
    Pediatr Transplant, 9(1): 97-100. [Abstract] [Full-text]
32. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.
    Pediatr Transplant, 9(1): 80-3. [Abstract] [Full-text]
33. Pediatric renal transplantation: single center experience.
    Pediatr Transplant, 9(1): 56-61. [Abstract] [Full-text]
34. Sodium ferric gluconate for post-transplant anemia in pediatric and young adult renal transplant recipients.
    Pediatr Transplant, 9(1): 43-6. [Abstract] [Full-text]
35. Excellent outcome in infants and small children with thrombophilias undergoing kidney transplantation.
    Pediatr Transplant, 9(1): 39-42. [Abstract] [Full-text]
36. Surgical complications in live-donor pediatric and adolescent renal transplantation: study of risk factors.
    Pediatr Transplant, 9(1): 33-8. [Abstract] [Full-text]
37. Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients.
    Pediatr Transplant, 9(1): 28-32. [Abstract] [Full-text]
38. Psychosocial impact of living-related kidney transplantation on donors and partners.
    Pediatr Nephrol, 20(2): 205-9. [Abstract] [Full-text]
39. Incidence and predictors of myocardial infarction after kidney transplantation.
    J Am Soc Nephrol, 16(2): 496-506. [Abstract] [Full-text]
40. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience.
    Pediatr Nephrol, 20(2): 210-6. [Abstract] [Full-text]
41. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
    Osteoporos Int, 16(2): 142-8. [Abstract] [Full-text]
42. Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation.
    Surgery, 137(2): 216-24. [Abstract] [Full-text]
43. Metabolic demand and renal mass supply affecting the early graft function after living donor kidney transplantation.
    Kidney Int, 67(2): 744-9. [Abstract] [Full-text]
44. Acute effect of CyA A (Neoral) on large artery hemodynamics in renal transplant patients.
    Kidney Int, 67(2): 732-7. [Abstract] [Full-text]
45. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.
    Kidney Int, 67(2): 714-20. [Abstract] [Full-text]
46. Iron overload in kidney transplants: prospective analysis of biochemical and genetic markers.
    Kidney Int, 67(2): 691-7. [Abstract] [Full-text]
47. Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats.
    Nephrol Dial Transplant, 20(2): 329-35. [Abstract] [Full-text]
48. Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients.
    Nephrol Dial Transplant, 20(2): 413-8. [Abstract] [Full-text]
49. Impact of graft failure on patient survival on dialysis: a comparison of transplant-naive and post-graft failure mortality rates.
    Nephrol Dial Transplant, 20(2): 387-91. [Abstract] [Full-text]
50. Stone-bearing live-donor kidneys for transplantation.
    BJU Int, 95(3): 394-7. [Abstract] [Full-text]
51. Surgery for localized prostate cancer after renal transplantation.
    BJU Int, 95(3): 319-22. [Abstract] [Full-text]

© 2004-2008 Kidney Transplant Research Today. All Rights Reserved.